DK1107789T3 - Sammensætninger og metoder til beskyttelse af organer, væv og celler mod beskadigelse formidlet af immunsystemet - Google Patents

Sammensætninger og metoder til beskyttelse af organer, væv og celler mod beskadigelse formidlet af immunsystemet

Info

Publication number
DK1107789T3
DK1107789T3 DK99946625T DK99946625T DK1107789T3 DK 1107789 T3 DK1107789 T3 DK 1107789T3 DK 99946625 T DK99946625 T DK 99946625T DK 99946625 T DK99946625 T DK 99946625T DK 1107789 T3 DK1107789 T3 DK 1107789T3
Authority
DK
Denmark
Prior art keywords
cells
methods
compositions
immune system
tissues
Prior art date
Application number
DK99946625T
Other languages
English (en)
Inventor
Robert Negrin
Ernest G Hope
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Application granted granted Critical
Publication of DK1107789T3 publication Critical patent/DK1107789T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99946625T 1998-08-24 1999-08-24 Sammensætninger og metoder til beskyttelse af organer, væv og celler mod beskadigelse formidlet af immunsystemet DK1107789T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9764098P 1998-08-24 1998-08-24
US38208899A 1999-08-24 1999-08-24
PCT/US1999/019337 WO2000010603A1 (en) 1998-08-24 1999-08-24 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage

Publications (1)

Publication Number Publication Date
DK1107789T3 true DK1107789T3 (da) 2008-11-03

Family

ID=26793493

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99946625T DK1107789T3 (da) 1998-08-24 1999-08-24 Sammensætninger og metoder til beskyttelse af organer, væv og celler mod beskadigelse formidlet af immunsystemet

Country Status (10)

Country Link
US (1) US20080241194A1 (da)
EP (2) EP1107789B1 (da)
JP (1) JP2004503463A (da)
AT (1) ATE399024T1 (da)
CA (1) CA2341558A1 (da)
DE (1) DE69938969D1 (da)
DK (1) DK1107789T3 (da)
ES (1) ES2310048T3 (da)
PT (1) PT1107789E (da)
WO (1) WO2000010603A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60042606D1 (de) * 1999-11-24 2009-09-03 Ernest G Hope Anti-angiogener zellulärer wirkstoff zur krebsbehanldung
EP1618891A1 (en) * 2003-03-31 2006-01-25 Kirin Beer Kabushiki Kaisha Method of inducing differentiation and proliferating regulatory t cell by anti-cd52 antibody and medicinal composition therefor
WO2006094703A1 (en) * 2005-03-03 2006-09-14 Inserm (Institut National De La Sante Et De La Recherche Medicale) Use of an antagonist of epac for treating human cardiac hypertrophy
MX2018008345A (es) 2016-01-11 2018-12-06 Univ Leland Stanford Junior Proteínas quiméricas y métodos de inmunoterapia.
IL260532B2 (en) 2016-01-11 2023-12-01 Univ Leland Stanford Junior Chimeric proteins- containing systems and uses thereof in regulating gene expression
CN111544585B (zh) 2019-02-11 2024-12-27 北京卡替医疗技术有限公司 一种可助推免疫细胞在体内扩增的佐剂
EP4431110A3 (en) 2020-01-19 2025-01-15 Chineo Medical Technology Co., Ltd. Enhanced receptor for improving immune cell function
JP2025522862A (ja) 2022-07-01 2025-07-17 フンダソン デー． アンナ デ ソメール シャンパリモー エ ドクター カルロス モンテス シャンパリモー － セントロ デ インベスティガソン ダ フンダソン シャンパリモー キメラポリペプチドシステム及び遺伝子調節の方法
WO2024168065A1 (en) 2023-02-08 2024-08-15 Tambo, Inc. System comprising modified whole cell payloads for targeted delivery
IL322674A (en) 2023-02-09 2025-10-01 Funda??O D Anna De Sommer Champalimaud E Dr Carlos Montez Champalimaud Found Control of gene expression in cells expressing gamma and delta receptors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995021614A1 (en) * 1994-02-09 1995-08-17 Ariad Pharmaceuticals, Inc. New protein trafficking inhibitors
JP2707407B2 (ja) * 1994-02-23 1998-01-28 呉羽化学工業株式会社 骨マトリックス合成促進剤
JPH107569A (ja) * 1996-06-18 1998-01-13 Kureha Chem Ind Co Ltd ベルベリン誘導体含有ｈｓｐ４７合成抑制剤

Also Published As

Publication number Publication date
EP1107789B1 (en) 2008-06-25
ES2310048T3 (es) 2008-12-16
JP2004503463A (ja) 2004-02-05
ATE399024T1 (de) 2008-07-15
PT1107789E (pt) 2008-10-08
EP1964572A2 (en) 2008-09-03
DE69938969D1 (de) 2008-08-07
EP1107789A4 (en) 2004-09-01
CA2341558A1 (en) 2000-03-02
EP1964572A3 (en) 2009-03-04
EP1107789A1 (en) 2001-06-20
US20080241194A1 (en) 2008-10-02
WO2000010603A1 (en) 2000-03-02

Similar Documents

Publication Publication Date Title
KR970703154A (ko) 공중합체-1의 개질물(copolymer-1 improvements in compositions of copolymers)
DK0946637T3 (da) Polymerfilm-sammensætning til kapsler
TR200103575T2 (tr) Sülfonamid ve sülfamid ikameli/katkılı imidazokinolinler
FI961022A0 (fi) Polylaktidikalvot
ATE274545T1 (de) Zusammensetzung, enthaltend ein nitroxid, einen promotor und eventuell einen radikalischen initiator
PT946100E (pt) Composicoes herbicidas contendo n-¬(4,6-dimetoxipirimidin-2-il)aminocarbonil|-5-metilsulfonamidometil-2-alcoxicarbonilbenzenossulfonamidas
ID17980A (id) Pirimido atau pirido tersubsitusi yang mengandung turunan-turunan 6,6-atau 6,7-bisiklis
ATE253063T1 (de) 5-ht1f-agonisten
DE69732309D1 (de) Primerzusammensetzungen für den Dentalbereich
DK1107789T3 (da) Sammensætninger og metoder til beskyttelse af organer, væv og celler mod beskadigelse formidlet af immunsystemet
TR199900310T2 (xx) Trombin inhibit�rleri
DK1109571T3 (da) Fremgangsmåde til behandling af saltafhængig hypertension
MXPA02000142A (es) Composiciones de heparina que inhiben los factores de coagulacion asociados con el coagulo.
MX9703702A (es) Adhesivos mejorados de laminacion basados en isocianato.
ATE239779T1 (de) Bleichmittelzusammensetzungen
ID16959A (id) Komposisi-komposisi herbisida sinergis lainnya.
ATE231001T1 (de) Verwendung von protein c inhibitor zur behandlung disseminierter intravasaler gerinnung (dic)
ATE306929T1 (de) Inositolphosphoglycan und ribose zur behandlung von ischämischen-reperfusionschaden
IT1304174B1 (it) Composizioni perossidiche
ATE222805T1 (de) Kollergang
ZA200110525B (en) Heparin compositions that inhibit clot associated coagulation factors.
ITMI972572A1 (it) Sega circolare da banco
MY113917A (en) Surgeon''s gloves from neoprene copolymers
UA28914A (uk) Засіб для терапії кольпіту
IT1295333B1 (it) Composizioni perossidiche